Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025
Posted On Saturday, May 03, 2025
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Result of General Meeting
Posted On Friday, May 02, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Posted On Friday, May 02, 2025
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
Posted On Friday, May 02, 2025
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
Posted On Friday, May 02, 2025
Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call
Posted On Friday, May 02, 2025
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
Posted On Friday, May 02, 2025
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers
Posted On Friday, May 02, 2025
Konik Capital Partners, LLC, a division of T.R. Winston & Co., Announces Official Launch
Posted On Friday, May 02, 2025
Longeveron® to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
Posted On Friday, May 02, 2025
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results
Posted On Friday, May 02, 2025
Repeat: EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025
Posted On Friday, May 02, 2025
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
Posted On Friday, May 02, 2025
ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
Posted On Friday, May 02, 2025
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
Posted On Friday, May 02, 2025
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
Posted On Friday, May 02, 2025
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
Posted On Friday, May 02, 2025
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print